CAS: 1338247-35-0 - Propanamide, N-[5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methyl-
Formula:C17H14Cl2F2N4OS
InChI:InChI=1S/C17H14Cl2F2N4OS/c1-8(2)16(26)23-17-22-7-13(27-17)12-6-11(15(20)21)24-25(12)14-9(18)4-3-5-10(14)19/h3-8,15H,1-2H3,(H,22,23,26)
InChI key:InChIKey=IVUGBSGLHRJSSP-UHFFFAOYSA-N
SMILES:O=C(NC1=NC=C(S1)C2=CC(=NN2C=3C(Cl)=CC=CC3Cl)C(F)F)C(C)C
- Synonyms:
- Propanamide, N-[5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methyl-
- BMS 5
N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyraMide
CAS:1338247-35-0
Formula:
C17H14Cl2F2N4OS
Purity:
98%
Color and Shape:
Solid
Molecular weight:
431.2871
Ref: IN-DA009CM3
5mg | 165.00 € | ||
10mg | 190.00 € | ||
50mg | 239.00 € | ||
100mg | 535.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Ref: 7W-GW8582
1mg | 218.00 € | ||
5mg | 312.00 € | ||
10mg | 454.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
BMS-5
CAS:1338247-35-0
BMS-5 (LIMKi 3) is a potent LIMK inhibitor with IC50s of 7 nM and 8 …
Formula:
C17H14Cl2F2N4OS
Purity:
95.83% - 99.88%
Color and Shape:
Solid
Molecular weight:
431.29
Ref: TM-T4598
1mg | 43.00 € | ||
2mg | 55.00 € | ||
5mg | 84.00 € | ||
10mg | 123.00 € | ||
25mg | 199.00 € | ||
50mg | 298.00 € | ||
100mg | 444.00 € | ||
1mL*10mM (DMSO) | 93.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
LIMKi 3
Controlled ProductCAS:1338247-35-0
Applications LIMKi 3 is a LIM kinase 1 (LIMK1) inhibitor that has antitumor properties. References …
Formula:
C17H14Cl2F2N4OS
Color and Shape:
Neat
Molecular weight:
431.287
Ref: TR-L397688
1mg | 83.00 € | ||
5mg | 209.00 € | ||
10mg | 336.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
LIMKi 3
CAS:1338247-35-0
LIMKi 3 is a sesquiterpene lactone that has been shown to activate the LIM kinase …
Formula:
C17H14Cl2F2N4OS
Purity:
Min. 95%
Molecular weight:
431.29 g/mol
Ref: 3D-NDC24735
5mg | 235.00 € | ||
50mg | 937.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025